Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa - Laura Dixon; Sara Bartel; Victoria Brown; Sarrah I. Ali; Susan Gamberg; Andrea Murphy; Katherine L. Brewer; Susan L. McElroy; Allan Kaplan; Abraham Nunes; Aaron R. Keshen (Journal of Eating Disorders, 2023)